1221069-65-3Relevant academic research and scientific papers
AMINOTHIENOPYRIDAZINE INHIBITORS OF TAU ASSEMBLY
-
Page/Page column 33, (2011/04/24)
The present invention is directed to methods of inhibiting a tauopathy in a patient by administration of a compound of formula (I): Novel aminothienopyridazine compounds are also described.
Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of Tau aggregation
Ballatore, Carlo,Brunden, Kurt R.,Piscitelli, Francesco,James, Michael J.,Crowe, Alex,Yao, Yuemang,Hyde, Edward,Trojanowski, John Q.,Lee, Virginia M.-Y.,Smith, Amos B.
experimental part, p. 3739 - 3747 (2010/08/06)
Agents capable of preventing the misfolding and sequestration of the microtubule-stabilizing protein tau into insoluble fibrillar aggregates hold considerable promise for the prevention and/or treatment of neurodegenerative tauopathies such as Alzheimer's
